| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8707406 | Oral Oncology | 2018 | 26 Pages |
Abstract
The current evidence to support or refute the prognostic utility of miRNAs in predicting cancer progression in OPMDs is equivocal. Further longitudinal prospective studies with solid study design are warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Haytham El-Sakka, Omar Kujan, Camile S. Farah,